Curate Biosciences Overview

  • Founded

  • 2002

Founded
  • Status

  • Private

  • Employees

  • 15

Employees
  • Latest Deal Type

  • Series C2

  • Latest Deal Amount

  • $18M

  • Investors

  • 7

Curate Biosciences General Information

Description

Operator of a pioneering biomedical company working with leading research institutes and universities intended to develop breakthrough technologies to get people better. The company's solution is an automatable benchtop system employing microfluidic deterministic cell separation technology through single-use cartridges, designed for both manufacturing and clinical improvement of T cell therapies, delivers the scale and performance required to advance CAR-T and TCR applications beyond today's limitations and now is advancing the application of its deterministic cell separation technology for its system releases targeting additional cell types, use cases, disease states, and workflow paradigms, enabling healthcare professionals to better combat diseases.

Contact Information

Website
www.curatebio.com
Formerly Known As
GPB Scientific
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Primary Office
  • 2715 Loker Avenue West
  • Carlsbad, CA 92010
  • United States
+1 (442) 000-0000

Curate Biosciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curate Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series C2) 23-Apr-2021 $18M 000.00 Completed Product Development
11. Angel (individual) 00.00 000.00 Completed Startup
10. Later Stage VC (Series C1) 02-Apr-2020 000.00 000.00 Completed Product Development
9. Later Stage VC (Series B) 20-Sep-2019 00.00 000.00 Completed Product Development
8. Grant 03-Jun-2019 00.000 00.000 Completed Product Development
7. Later Stage VC (Series A1) 04-Jun-2018 00.00 00.000 Completed Product Development
6. Accelerator/Incubator 00.000 Completed Pre-Clinical Trials
5. Later Stage VC (Series A) 27-Jan-2016 00.00 00.000 Completed Product Development
4. Accelerator/Incubator 28-Oct-2015 $1.99M Completed Pre-Clinical Trials
3. Seed Round 17-Jul-2015 $1.99M $1.99M Completed Pre-Clinical Trials
To view Curate Biosciences’s complete valuation and funding history, request access »

Curate Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 276,150 $0.000010 8% $7 $7 1x $7 1.57%
Series A 1,758,274 $0.000010 8% $4 $4 1x $4 10.02%
To view Curate Biosciences’s complete cap table history, request access »

Curate Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a pioneering biomedical company working with leading research institutes and universities intended to develo
Biotechnology
Carlsbad, CA
15 As of 2022
000.00
00000000000 000.00

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000 000000000
Emeryville, CA
000 As of 0000
00000
00000000000 00000

000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
000000000 00000 (0000000000)
Wilbraham, MA
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curate Biosciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Berkeley Lights Formerly VC-backed Emeryville, CA 000 00000 00000000000 00000
000000000 000000 Formerly VC-backed Wilbraham, MA 00 000.00 000000&0 000.00
00000000 000000 Private Debt Financed Bergisch Gladbach, Germany 0000 000000000
000000000 0000 Corporation Bad Homburg, Germany 0000
0000000 00000 Venture Capital-Backed Santa Clara, CA 00 0000000000 0
You’re viewing 5 of 5 competitors. Get the full list »

Curate Biosciences Patents

  • 92

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Curate Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3793737-A1 Combined purification and concentration by deterministic lateral displacement with recirculation product Pending 13-May-2018 000000000
JP-2021522834-A Bond purification and enrichment by deterministic lateral displacement using product recirculation Pending 13-May-2018 000000000
AU-2019270934-A1 Combined purification and concentration by deterministic lateral displacement with recirculation product Pending 13-May-2018 000000000
CA-3099717-A1 Combined purification and concentration by deterministic lateral displacement with recirculation of product Pending 13-May-2018 000000000
US-20210261907-A1 Combined purification and concentration by deterministic lateral displacement with recirculation of product Pending 13-May-2018 C12M47/04
To view Curate Biosciences’s complete patent history, request access »

Curate Biosciences Executive Team (6)

Name Title Board Seat Contact Info
Michael Grisham Founder, Chief Executive Officer & Chairman
Jason Walsh Chief Financial Officer
Tony Ward Chief Technology Officer
Gaurav Vij Chief Business Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Curate Biosciences Board Members (6)

Name Representing Role Since
James Farinholt Jr. Self Board Member 000 0000
Janis Naeve Ph.D Amgen Ventures Board Observer 000 0000
Justin Klein MD Vensana Capital Board Member 000 0000
Michael Grisham Curate Biosciences Founder, Chief Executive Officer & Chairman 000 0000
Ned Ruffin JD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Curate Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curate Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Vensana Capital Venture Capital Minority 000 0000 000000 0
Gilo Ventures Venture Capital Minority 000 0000 000000 0
Thylacine Capital Venture Capital Minority 000 0000 000000 0
Bio, Tech and Beyond Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial